Saniona announces that the exercise period of warrants of series TO3 begins on April 6, 2021
March 31, 2021
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the exercise period for the warrants of series TO3, which were issued in connection with Saniona’s rights issue and directed issue in the first quarter of 2020, will begin on April 6. The exercise period runs from April 6 until and including April 20, 2021.
The holders of warrants of series TO3 have the right to subscribe for one (1) new share in Saniona for each warrant held at a price of SEK 25.00 per share. The subscription price has been determined within the interval of SEK 25.00-30.00 per share in accordance with the warrant terms based on the volume weighted average price of Saniona’s share during the period from and including March 17, 2021, to and including March 30, 2021. If all warrants of series TO3 are fully exercised, Saniona will be allocated approximately SEK 37 million (before issuing costs). The TO3 warrants will cease being traded on April 16, 2021. The holders of warrants must apply for subscription of new shares, by exercising the warrants, no later than 5:00 p.m. CET, April 20, 2021.
“Saniona recently concluded our most successful year to date, during which we transformed our business model to maximize the value of our innovative medicines, raised SEK 567 million to fund our operations into the second half of 2022, and built our U.S. operations to facilitate access to the U.S. patients, physicians and financial markets that will be critical to our success,” said Rami Levin, President & CEO. “We started 2021 with the achievement of two important milestones: receiving orphan drug designation from the U.S. FDA for Tesomet in Prader-Willi syndrome (PWS) and gaining clarity on the the regulatory path forward for Tesomet in hypothalamic obesity (HO). Now we are continuing to build momentum and preparing to simultaneously initiate three clinical trials by mid year: two Phase 2b trials for Tesomet in hypothalamic obesity and Prader-Willi syndrome and a Phase 1 trial with SAN711 for rare neuropathic disorders. We remain in a strong position to advance our innovative treatments for rare diseases. We now invite shareholders to exercise warrants of series TO3, which will generate additional funding to further strengthen our position.”
Warrants of series TO3 in brief:
- Exercise price: Each warrant of series TO3 entitles the holder the right to subscribe for one (1) new share in Saniona at a subscription price of SEK 25.00.
- Issue volume: There are 1,479,742 outstanding warrants of series TO3. If all warrants of series TO3 are fully exercised Saniona will receive gross issuing proceeds of approximately SEK 37 million.
- Current number of shares in Saniona: 62,372,831.
Upon full exercise of all warrants of series TO3, the number of shares in Saniona will increase by 1,479,742 to 63,852,573 and the share capital will increase by SEK 73,987.10 to SEK 3,192,628.65. This entails a dilution of approximately 2.3 percent based on the number of shares in Saniona after full exercise of all warrants of series TO3. The warrants of series TO3 are listed for trading on Nasdaq Stockholm with the short name "SANION TO3" and ISIN SE0013775319.
Important dates for warrants of series TO3:
- April 6, 2021 – The exercise period begins
- April 16, 2021 – Last day of trading in the warrant
- April 20, 2021 – The exercise period ends
- April 23, 2021 – Planned date for publication of the warrant exercise outcome
- May 18, 2021 – Planned date for conversion of interim shares (from exercised warrants) to ordinary shares
Subscription forms will be made available from April 6 on Saniona’s, Sedermera Fondkommission’s, and Nordic Issuing’s respective websites. Full terms and conditions for the warrants of series TO3 are provided via Saniona’s website.
Action from you as a warrant holder is required – how to exercise your warrants of series TO3:
The TO3 warrants will cease being traded on April 16, 2021. In order for your warrants not to expire, your action is required. You must apply for subscription of new shares, by exercise of warrants, no later than 5:00 p.m. CET April 20, 2021.
You can have your warrants registered in two ways:
1. In a securities custody account with a bank or other nominee (for example, Avanza or Nordnet), in an investment savings account (Sw. Investeringssparkonto) or endowment account (Sw. Kapitalförsäkring). Your warrants are then nominee registered.
2. In a VP-account (a VP-account starts with three zeros). Your warrants are then directly registered.
If your warrants are nominee registered
Subscription and payment of new shares, by exercise of warrants, shall be made to the account-holding bank/nominee with which the warrants are registered. The subscription and payment shall be made in accordance with instructions from each such bank or nominee. Usually, the bank/nominee sends out a digital notice to the account holder, otherwise it is enough to log into the securities custody account from the first day in the exercise period in order to get instructions on how to exercise warrants for subscription of new shares. If you do not find these instructions, please contact your bank or trustee. Please note that banks and other nominees may set different time limits for the last day for subscription, hence it is recommended to contact the account-holding bank/nominee early in the exercise period. Subscribed and payed for shares may be entered as “interim shares” or “IA” into your securities custody account until registration of the issue is completed with the Swedish Companies Registration Office, whereby interim shares will automatically be converted to ordinary shares in Saniona.
If your warrants are directly registered
Subscription of new shares, by exercise of warrants, shall be made by sending a completed subscription form to Nordic Issuing. In conjunction with sending the completed subscription form, payment must be made to Nordic Issuing in accordance with the payment details stated on the subscription form. Completed subscription form and payment must be registered with Nordic Issuing no later than 5:00 p.m. CET April 20, 2021. Subscribed and payed for shares will be entered as “interim shares” or “IA” into your VP-account until registration of the issue is completed with the Swedish Companies Registration Office, whereby interim shares will automatically be converted to ordinary shares in Saniona.
Financial advisor, legal advisor, and issuing agent
Sedermera Fondkommission is financial advisor, Setterwalls Advokatbyrå is legal advisor, and Nordic Issuing is issuing agent to Saniona in connection with the issue and exercise of warrants.
For more information regarding the warrants of series TO3, please contact
Nordic Issuing, Phone: +46 40-632 00 20, Email: email@example.com
For more information, please contact
Trista Morrison, Chief Communications Officer, Saniona. Office: + 1 (781) 810-9227. Email: firstname.lastname@example.org
The information was submitted for publication, through the agency of the contact person set out above, at 8:00 CET on 31 March 2021.
Saniona is a biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for rare disease patients around the world. The company’s lead product candidate, Tesomet, is in mid-stage clinical trials for hypothalamic obesity and Prader-Willi syndrome, severe rare disorders characterized by uncontrollable hunger and intractable weight gain. Saniona’s robust drug discovery engine has generated a library now consisting of more than 20,000 proprietary modulators of ion channels, a significantly untapped drug class that is scientifically validated. Lead candidate SAN711 is entering Phase 1 for rare neuropathic disorders, with SAN903 for rare inflammatory and fibrotic disorders advancing through preclinical studies. Led by an experienced scientific and operational team, Saniona has an established research organization in Copenhagen, Denmark and is building its corporate office in the Boston, Massachusetts area, U.S. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com.
The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, warrants or other securities in Saniona. An offer to the persons concerned to subscribe for units consisting of warrants in Saniona has only been made through the prospectus that Saniona published on February 14, 2020.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Vertex Welcomes Dynamic Leader Yvette C. Burton, Ph.D. As Chief People Innovation Officer12.4.2021 14:47:00 CEST | Press release
Executive Leadership to Advance Company’s Global Workforce Strategy KING OF PRUSSIA, Pa., April 12, 2021 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, is honored to welcome Yvette C. Burton, Ph.D. as its first Chief People Innovation Officer, effective immediately. Dr. Burton is responsible for shaping the company’s global strategic workforce planning efforts and leading organizational programs to advance inclusion and diversity. Burton comes to Vertex from Columbia University, where she was the academic director of the school’s Human Capital Management Program. She will draw on her executive expertise, including over 20 years in high-impact human capital strategies for the media, consumer, industrial product, and defense industries, to lead and engage employees worldwide. Burton was also named to Crain's New York inaugural list of Notable LGBTQ Leaders and Executives in 2020. “We welcome Yvette and her rare c
Industry Leading SAFR Facial Recognition for Live Video Integrated with Geutebrück VMS12.4.2021 13:00:00 CEST | Press release
Featuring real-time, automated, low-bias identification of opt-in staff and persons of interest SEATTLE, April 12, 2021 (GLOBE NEWSWIRE) -- SAFR from RealNetworks, Inc. (NASDAQ: RNWK) today announced that its SAFR facial recognition system for live video is now integrated with the Geutebrück G-Core VMS (Video Management System). SAFR for Geutebrück is an AI layer that runs on top of the G-Core VMS which provides advanced video analytics that save time and increase efficiency of surveillance operations. The best-in-class integration features live video overlays that display event details, streamlined enrollment of individuals appearing on the Geutebrück VMS directly into the SAFR identity database, and custom alarms and notifications that notify security personnel of SAFR events directly within the VMS. With so many cameras deployed, it’s impossible for security staff to monitor them effectively. SAFR matches faces appearing in live video feeds against watchlist images more effectively
Rockridge Stakes Additional Ground at the Knife Lake Copper Project, Saskatchewan12.4.2021 13:00:00 CEST | Press release
VANCOUVER, British Columbia, April 12, 2021 (GLOBE NEWSWIRE) -- Rockridge Resources Ltd. (TSX-V: ROCK) (OTCQB: RRRLF) (Frankfurt: RR0) (“Rockridge” or the “Company”) is pleased to announce that it has recently acquired additional mineral rights through staking at its Knife Lake Copper Project located in Saskatchewan, Canada (the “Knife Lake Project” or “Property”). The Knife Lake Project, now consisting of 81 dispositions totaling 55,471 hectares (137,069 acres), is an advanced-stage copper, silver, zinc and cobalt exploration property in Saskatchewan. With the recent staking, the Company has increased the project area by 70% from 32,663 hectares (80,712 acres). Knife Lake Claims Map: https://www.rockridgeresourcesltd.com/_resources/images/Knife-Lake-Region-20210331-003.jpg Based on encouraging observations made during the current drill program the newly acquired claims are considered to be highly prospective for VMS mineralization. The staking completed has added to the land package s
Signify share repurchase periodic update12.4.2021 13:00:00 CEST | Press release
Press Release April 12, 2021 Signify share repurchase periodic update Eindhoven, the Netherlands –Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has repurchased 131,684 shares in the period April 6 to April 9, 2021. The shares were repurchased at an average price of EUR 44.36 per share and an aggregate amount of EUR 5.8 million. These repurchases were made as part of the company’s repurchase program, which was announced on February 25, 2021. Signify will use the shares to cover obligations arising from its long-term incentive performance share plan and other employee share plans. The total number of shares repurchased under this program to date is 968,157 shares for a total consideration of EUR 39.3 million. Details on the share buyback transactions can be found here. --- END --- For further information, please contact: Signify Investor Relations Thelke Gerdes Tel: +31 6 1801 7131 E-mail: email@example.com Signify Corporate Communications Elco
Effnet licenses its ASN.1 5G Toolset and 5G gNB CU-UP software components12.4.2021 12:07:15 CEST | Press release
Luleå, 2021-04-12 -- Effnet, a subsidiary of Effnetplattformen AB and a leading provider of 5G protocol stack software for terminals and containerized 5G RAN software as well as Header Compression software, announces today that it has licensed its ASN.1 5G Toolset and 5G gNB CU-UP software components to a leading provider of open and cloud-native 4G and 5G RAN software solutions. Effnet ASN.1 5G Toolset uses modern C++. It is portable, robust and provides high performance. It currently has support for ASN.1 in 3GPP Release 15 (RRC, F1AP, E1AP, NGAP, XnAP and NRPPa) specifications and the O-RAN E2AP specification. For more information, visit http://www.effnet.com/products/asn1/. Effnet 5G gNB CU-UP is a high quality and high-performance user plane software solution used in the Central Unit (CU) of a 5G gNB. Together with the Effnet DU software, this is a critical component to deliver data traffic (user plane) at exceedingly high rates. The software can deliver better radio resource effi
Statkraft bygger tre vindparker i Chile – verdens sørligste land12.4.2021 12:00:00 CEST | Pressemelding
(Santiago/Oslo, 12. april 2021) Statkraft skal for første gang bygge vindkraftverk i Chile, og øker dermed sin produksjonskapasitet for fornybar energi i det søramerikanske landet, hvor etterspørselen etter vann-, vind- og solkraft er stigende. Sammen med selskapets eksisterende vannkraftportefølje i Chile, vil Statkraft nå en produksjonskapasitet på 366 megawatt (MW) innen utgangen av 2023. Det 102 MW store vindprosjektet Torsa består av tre vindparker, med til sammen 19 turbiner fra den tyske produsenten Nordex. Samlet forventes vindparkene å produsere mer enn 300 GWh med fornybar energi i året – nok til å forsyne 100.000 gjennomsnittlige chilenske hjem. Prosjektet ligger i O’Higgins-regionen, 124 kilometer sør for hovedstaden Santiago. - Disse tre vindparkene øker ikke bare vår produksjonskapasitet i Chile; de utvider vår fornybarportefølje til å for første gang omfatte vindkraft. Framover planlegger vi også å inkludere solkraft i produksjonsmiksen vår, sier Statkrafts konserndirekt
Statkraft to build its first wind farms in the world’s southernmost country Chile12.4.2021 12:00:00 CEST | Press release
(Santiago/Oslo, 12 April, 2021) Statkraft, Europe’s largest renewable energy generator, will build its first wind farms in Chile, expanding its renewable energy generation capacity in the South American country amid an increasing demand for hydro, wind and solar power in the southernmost nation in the world. Combined with the company’s existing hydropower assets, Statkraft will reach a generating capacity of 366 megawatt (MW) by the end of 2023. The 102 MW Torsa wind power project consists of three wind farms, totalling 19 wind turbines supplied by German manufacturer Nordex. In total, the wind farms are expected to produce more than 300 GWh of renewable energy annually; enough power to supply 100,000 average Chilean households. The project is located in the O’Higgins region, 124 kilometres south of the capital Santiago. “These three wind farms are not only expanding our generating capacity in Chile; it is broadening our renewable energy portfolio by including wind power for the first